Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Acta Neuropathol ; 138(6): 1013-1031, 2019 12.
Article in English | MEDLINE | ID: mdl-31463572

ABSTRACT

MSTO1 encodes a cytosolic mitochondrial fusion protein, misato homolog 1 or MSTO1. While the full genotype-phenotype spectrum remains to be explored, pathogenic variants in MSTO1 have recently been reported in a small number of patients presenting with a phenotype of cerebellar ataxia, congenital muscle involvement with histologic findings ranging from myopathic to dystrophic and pigmentary retinopathy. The proposed underlying pathogenic mechanism of MSTO1-related disease is suggestive of impaired mitochondrial fusion secondary to a loss of function of MSTO1. Disorders of mitochondrial fusion and fission have been shown to also lead to mitochondrial DNA (mtDNA) depletion, linking them to the mtDNA depletion syndromes, a clinically and genetically diverse class of mitochondrial diseases characterized by a reduction of cellular mtDNA content. However, the consequences of pathogenic variants in MSTO1 on mtDNA maintenance remain poorly understood. We present extensive phenotypic and genetic data from 12 independent families, including 15 new patients harbouring a broad array of bi-allelic MSTO1 pathogenic variants, and we provide functional characterization from seven MSTO1-related disease patient fibroblasts. Bi-allelic loss-of-function variants in MSTO1 manifest clinically with a remarkably consistent phenotype of childhood-onset muscular dystrophy, corticospinal tract dysfunction and early-onset non-progressive cerebellar atrophy. MSTO1 protein was not detectable in the cultured fibroblasts of all seven patients evaluated, suggesting that pathogenic variants result in a loss of protein expression and/or affect protein stability. Consistent with impaired mitochondrial fusion, mitochondrial networks in fibroblasts were found to be fragmented. Furthermore, all fibroblasts were found to have depletion of mtDNA ranging from 30 to 70% along with alterations to mtDNA nucleoids. Our data corroborate the role of MSTO1 as a mitochondrial fusion protein and highlight a previously unrecognized link to mtDNA regulation. As impaired mitochondrial fusion is a recognized cause of mtDNA depletion syndromes, this novel link to mtDNA depletion in patient fibroblasts suggests that MSTO1-deficiency should also be considered a mtDNA depletion syndrome. Thus, we provide mechanistic insight into the disease pathogenesis associated with MSTO1 mutations and further define the clinical spectrum and the natural history of MSTO1-related disease.


Subject(s)
Cell Cycle Proteins/genetics , Cerebellar Diseases/genetics , Cytoskeletal Proteins/genetics , DNA, Mitochondrial , Mitochondrial Diseases/genetics , Muscular Dystrophies/genetics , Mutation , Adolescent , Adult , Atrophy , Cells, Cultured , Cerebellar Diseases/diagnostic imaging , Cerebellar Diseases/pathology , Cerebellar Diseases/physiopathology , Child , DNA Copy Number Variations , Female , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Male , Middle Aged , Mitochondrial Diseases/diagnostic imaging , Mitochondrial Diseases/pathology , Mitochondrial Diseases/physiopathology , Muscles/pathology , Muscular Dystrophies/diagnostic imaging , Muscular Dystrophies/pathology , Muscular Dystrophies/physiopathology , Phenotype , Young Adult
2.
Clin Genet ; 94(3-4): 303-312, 2018 10.
Article in English | MEDLINE | ID: mdl-29851065

ABSTRACT

A novel autosomal recessive disorder characterized by pre- and postnatal growth restriction with microcephaly, distinctive craniofacial features, congenital alopecia, hypoplastic kidneys with renal insufficiency, global developmental delay, severe congenital sensorineural hearing loss, early mortality, hydrocephalus, and genital hypoplasia was observed in 4 children from 3 families of New Mexican Hispanic heritage. Three of the children died before 3 years of age from uremia and/or sepsis. Exome sequencing of the surviving individual identified a homozygous c.587T>C (p.Ile196Thr) mutation in ZPR1 Zinc Finger (ZPR1) that segregated appropriately in her family. In a second family, the identical variant was shown to be heterozygous in the affected individual's parents and not homozygous in any of her unaffected siblings. ZPR1 is a ubiquitously expressed, highly conserved protein postulated to transmit proliferative signals from the cell membrane to the nucleus. Structural modeling reveals that p.Ile196Thr disrupts the hydrophobic core of ZPR1. Patient fibroblast cells showed no detectable levels of ZPR1 and the cells showed a defect in cell cycle progression where a significant number of cells remained arrested in the G1 phase. We provide genetic and molecular evidence that a homozygous missense mutation in ZPR1 is associated with a rare and recognizable multisystem syndrome.


Subject(s)
Abnormalities, Multiple/genetics , Alopecia/genetics , Facies , Growth Disorders/genetics , Kidney/abnormalities , Membrane Transport Proteins/genetics , Microcephaly/genetics , Mutation , Child, Preschool , Female , Genes, Recessive , Humans , Male
3.
Neurogenetics ; 19(1): 61-65, 2018 01.
Article in English | MEDLINE | ID: mdl-29247375

ABSTRACT

Occipital cortical malformation is a rare neurodevelopmental disorder characterized by pachygyria and polymicrogyria of the occipital lobes as well as global developmental delays and seizures. This condition is due to biallelic, loss-of-function mutations in LAMC3 and has been reported in four unrelated families to date. We report an individual with global delays, seizures, and polymicrogyria that extends beyond the occipital lobes and includes the frontal, parietal, temporal, and occipital lobes. Next-generation sequencing identified a homozygous nonsense mutation in LAMC3: c.3190C>T (p.Gln1064*). This finding extends the cortical phenotype associated with LAMC3 mutations.


Subject(s)
Epilepsy/genetics , Laminin/genetics , Polymicrogyria/genetics , Adolescent , Brain/diagnostic imaging , Codon, Nonsense , Epilepsy/complications , Epilepsy/diagnostic imaging , Female , High-Throughput Nucleotide Sequencing , Humans , Polymicrogyria/complications , Polymicrogyria/diagnostic imaging
4.
Clin Genet ; 93(2): 301-309, 2018 02.
Article in English | MEDLINE | ID: mdl-28708278

ABSTRACT

The inherited peripheral neuropathies (IPNs) are characterized by marked clinical and genetic heterogeneity and include relatively frequent presentations such as Charcot-Marie-Tooth disease and hereditary motor neuropathy, as well as more rare conditions where peripheral neuropathy is associated with additional features. There are over 250 genes known to cause IPN-related disorders but it is estimated that in approximately 50% of affected individuals a molecular diagnosis is not achieved. In this study, we examine the diagnostic utility of whole-exome sequencing (WES) in a cohort of 50 families with 1 or more affected individuals with a molecularly undiagnosed IPN with or without additional features. Pathogenic or likely pathogenic variants in genes known to cause IPN were identified in 24% (12/50) of the families. A further 22% (11/50) of families carried sequence variants in IPN genes in which the significance remains unclear. An additional 12% (6/50) of families had variants in novel IPN candidate genes, 3 of which have been published thus far as novel discoveries (KIF1A, TBCK, and MCM3AP). This study highlights the use of WES in the molecular diagnostic approach of highly heterogeneous disorders, such as IPNs, places it in context of other published neuropathy cohorts, while further highlighting associated benefits for discovery.


Subject(s)
Charcot-Marie-Tooth Disease/genetics , Exome Sequencing , High-Throughput Nucleotide Sequencing , Peripheral Nervous System Diseases/genetics , Acetyltransferases/genetics , Charcot-Marie-Tooth Disease/diagnosis , Charcot-Marie-Tooth Disease/pathology , Exome/genetics , Female , Humans , Intracellular Signaling Peptides and Proteins/genetics , Kinesins/genetics , Male , Mutation , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/pathology , Protein Serine-Threonine Kinases/genetics
5.
NPJ Genom Med ; 2: 14, 2017.
Article in English | MEDLINE | ID: mdl-29263829

ABSTRACT

Most monogenic diseases can be viewed as conditions caused by dysregulated protein activity; therefore, drugs can be used to modulate gene expression, and thus protein level, possibly conferring clinical benefit. When considering repurposing drugs for loss of function diseases, there are three classes of genetic disease amenable to an increase of function; haploinsufficient dominant diseases, those secondary to hypomorphic recessive alleles, and conditions with rescuing paralogs. This therapeutic model then brings the questions: how frequently do such clinically useful drug-gene interactions occur and what is the most rapid and efficient route by which to identify them. Here we compare three approaches: (1) mining of pre-existing system-wide transcriptomal datasets such as Connectivity Map; (2) utilization of a proprietary causal reasoning engine knowledge base; and, (3) a targeted drug screen using clinically accepted agents tested against normal human fibroblasts. We have determined the validation rate of these approaches for 76 diseases (i.e., in vitro fibroblast mRNA increase); for the Connectivity Map, approximately 5% of tested putative drug-gene interactions validated, for causal reasoning engine knowledge base the rate was 10%, and for the targeted drug screen 9%. The degree of overlap between these methodologies was low suggesting they are complementary not redundant approaches to identify putative drug-gene interactions. Although the validation rate was low, a number of drug-gene interactions were successfully identified and are now being investigated for protein induction and in vivo effect. This analysis establishes potentially valuable therapeutic leads as well as useful benchmarks for the thousands of currently untreatable rare genetic conditions.

6.
Eur J Med Genet ; 60(7): 359-364, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28377321

ABSTRACT

The genetic causes of intellectual disability (ID) are heterogeneous and include both chromosomal and monogenic etiologies. The X-chromosome is known to contain many ID-related genes and males show a marked predominance for intellectual disability. Here we report two females with syndromic intellectual disability. The first individual was relatively mild in her presentation with mild-moderate intellectual disability, hydronephrosis and altered pigmentation along the lines of Blaschko without additional congenital anomalies. A second female presented shortly after birth with dysmorphic facial features, post-axial polydactyly and, on follow-up assessment, demonstrated moderate intellectual disability. Chromosomal studies for Individual 1 identified an X-chromosome deletion due to a de novo pericentric inversion; the inversion breakpoint was associated with deletion of the 5'UTR of the USP9X, a gene which has been implicated in a syndromic intellectual disability affecting females. The second individual had a de novo frameshift mutation detected by whole-exome sequencing that was predicted to be deleterious, NM_001039590.2 (USP9X): c.4104_4105del (p.(Arg1368Serfs*2)). Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum. The extent of the congenital malformations observed in Individual 1 was less striking than Individual 2 and other individuals previously reported in the literature, and suggests that USP9X mutations in females can have a wider spectrum of presentation than previously appreciated.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Frameshift Mutation , Intellectual Disability/genetics , Phenotype , Ubiquitin Thiolesterase/genetics , 5' Untranslated Regions , Abnormalities, Multiple/diagnosis , Adult , Child, Preschool , Chromosomes, Human, X/genetics , Female , Haploinsufficiency , Humans , Infant , Intellectual Disability/diagnosis , Syndrome
7.
Clin Genet ; 92(3): 281-289, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28170084

ABSTRACT

BACKGROUND: Recent clinical whole exome sequencing (WES) cohorts have identified unanticipated multiple genetic diagnoses in single patients. However, the frequency of multiple genetic diagnoses in families is largely unknown. AIMS: We set out to identify the rate of multiple genetic diagnoses in probands and their families referred for analysis in two national research programs in Canada. MATERIALS & METHODS: We retrospectively analyzed WES results for 802 undiagnosed probands referred over the past 5 years in either the FORGE or Care4Rare Canada WES initiatives. RESULTS: Of the 802 probands, 226 (28.2%) were diagnosed based on mutations in known disease genes. Eight (3.5%) had two or more genetic diagnoses explaining their clinical phenotype, a rate in keeping with the large published studies (average 4.3%; 1.4 - 7.2%). Seven of the 8 probands had family members with one or more of the molecularly diagnosed diseases. Consanguinity and multisystem disease appeared to increase the likelihood of multiple genetic diagnoses in a family. CONCLUSION: Our findings highlight the importance of comprehensive clinical phenotyping of family members to ultimately provide accurate genetic counseling.


Subject(s)
Exome Sequencing , Family , Genetic Association Studies , Genetic Diseases, Inborn/diagnosis , Genetic Diseases, Inborn/genetics , Genetic Predisposition to Disease , Canada/epidemiology , Child, Preschool , Consanguinity , Female , Genetic Diseases, Inborn/epidemiology , Genetic Testing , Genotype , Humans , Male , Mutation , Pedigree , Phenotype , Retrospective Studies , Siblings , Exome Sequencing/methods
8.
Clin Genet ; 91(3): 426-430, 2017 03.
Article in English | MEDLINE | ID: mdl-27684565

ABSTRACT

Mutations in GLE1 cause two recessive subtypes of arthrogryposis multiplex congenita (AMC), a condition characterized by joint contractures at birth, and all previously reported patients died in the perinatal period. GLE1 related AMC has been almost exclusively reported in the Finnish population and is caused by a relatively common pathogenic splicing mutation in that population. Here, we report two non-Finnish brothers with novel compound heterozygous splicing mutations in GLE1, one of whom has survived to 12 years of age. We also demonstrate low levels of residual wild type transcript in fibroblasts from the surviving brother, suggesting that this residual wild-type transcript may contribute to the relatively longer-term survival in this family. We provide a detailed clinical report on the surviving patient, providing the first insight into the natural history of this rare neuromuscular disease. We also suggest that lethal congenital contracture syndrome 1 (LCCS1) and lethal arthrogryposis with anterior horn disease (LAAHD), the two AMC subtypes related to GLE1, do not have sufficient clinical or molecular differentiation to be considered allelic disorders. Rather, GLE1 mutations cause a variable spectrum of AMC severity including a non-lethal variant described herein.


Subject(s)
Arthrogryposis/genetics , Nucleocytoplasmic Transport Proteins/genetics , Arthrogryposis/diagnosis , Arthrogryposis/physiopathology , Child , Finland , Gastrostomy , Genotype , Humans , Infant, Newborn , Male , Mutation , Pedigree , RNA Splicing/genetics
9.
Clin Genet ; 91(5): 708-716, 2017 May.
Article in English | MEDLINE | ID: mdl-27718516

ABSTRACT

Post-translational protein modifications exponentially expand the functional complement of proteins encoded by the human genome. One such modification is the covalent addition of a methyl group to arginine or lysine residues, which is used to regulate a substantial proportion of the proteome. Arginine and lysine methylation are catalyzed by protein arginine methyltransferase (PRMTs) and protein lysine methyltransferase proteins (PKMTs), respectively; each methyltransferase has a specific set of target substrates. Here, we report a male with severe intellectual disability, facial dysmorphism, microcephaly, short stature, brachydactyly, cryptorchidism and seizures who was found to have a homozygous 15,309 bp deletion encompassing the transcription start site of PRMT7, which we confirmed is functionally a null allele. We show that the patient's cells have decreased levels of protein arginine methylation, and that affected proteins include the essential histones, H2B and H4. Finally, we demonstrate that patient cells have altered Wnt signaling, which may have contributed to the skeletal abnormalities. Our findings confirm the recent disease association of PRMT7, expand the phenotypic manifestations of this disorder and provide insight into the molecular pathogenesis of this new condition.


Subject(s)
Brachydactyly/genetics , Intellectual Disability/genetics , Microcephaly/genetics , Protein-Arginine N-Methyltransferases/genetics , Abnormalities, Multiple/genetics , Arginine/metabolism , Child, Preschool , Chromosomes, Human, Pair 16 , Face/abnormalities , Female , Fingers/abnormalities , Gene Deletion , Humans , Infant , Infant, Newborn , Male , Transcription Initiation Site , Wnt Signaling Pathway/genetics
10.
Clin Genet ; 91(1): 92-99, 2017 01.
Article in English | MEDLINE | ID: mdl-27102954

ABSTRACT

THOC6 is a part of the THO complex, which is involved in coordinating mRNA processing with export. The THO complex interacts with additional components to form the larger TREX complex (transcription export complex). Previously, a homozygous missense mutation in THOC6 in the Hutterite population was reported in association with syndromic intellectual disability. Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in THOC6 associated with intellectual disability and additional clinical features. Two of the patients were compound heterozygous for a stop and a missense mutation, and the third was homozygous for a missense mutation; the missense mutations were predicted to be pathogenic by in silico analysis and modeling. Clinical features of the three newly identified patients and those previously reported are reviewed; intellectual disability is moderate to severe, and malformations are variable including renal and heart defects, cleft palate, microcephaly, and corpus callosum dysgenesis. Facial features are variable and include tall forehead, short upslanting palpebral fissures +/- deep set eyes, and a long nose with overhanging columella. These subtle facial features render the diagnosis difficult to make in isolation with certainty. Our results expand the mutational and clinical spectrum of this rare disease, confirm that THOC6 is an intellectual disability causing gene, while providing insight into the importance of the THO complex in neurodevelopment.


Subject(s)
Genetic Predisposition to Disease/genetics , Intellectual Disability/genetics , Mutation, Missense , RNA-Binding Proteins/genetics , Adolescent , Child , Exome/genetics , Female , Genes, Recessive , Genotype , Humans , Intellectual Disability/pathology , Male , Models, Molecular , Phenotype , Protein Domains , RNA-Binding Proteins/chemistry , Sequence Analysis, DNA/methods , Severity of Illness Index , Syndrome
11.
Clin Genet ; 89(3): 275-84, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26283276

ABSTRACT

An accurate diagnosis is an integral component of patient care for children with rare genetic disease. Recent advances in sequencing, in particular whole-exome sequencing (WES), are identifying the genetic basis of disease for 25-40% of patients. The diagnostic rate is probably influenced by when in the diagnostic process WES is used. The Finding Of Rare Disease GEnes (FORGE) Canada project was a nation-wide effort to identify mutations for childhood-onset disorders using WES. Most children enrolled in the FORGE project were toward the end of the diagnostic odyssey. The two primary outcomes of FORGE were novel gene discovery and the identification of mutations in genes known to cause disease. In the latter instance, WES identified mutations in known disease genes for 105 of 362 families studied (29%), thereby informing the impact of WES in the setting of the diagnostic odyssey. Our analysis of this dataset showed that these known disease genes were not identified prior to WES enrollment for two key reasons: genetic heterogeneity associated with a clinical diagnosis and atypical presentation of known, clinically recognized diseases. What is becoming increasingly clear is that WES will be paradigm altering for patients and families with rare genetic diseases.


Subject(s)
Exome , Genes , Genetic Diseases, Inborn/diagnosis , Mutation , Sequence Analysis, DNA , Canada , Child , Genetic Diseases, Inborn/genetics , High-Throughput Nucleotide Sequencing , Humans
12.
Clin Genet ; 88(6): 558-64, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25589244

ABSTRACT

Limb girdle muscular dystrophy (LGMD) is a heterogeneous group of genetic disorders leading to progressive muscle degeneration and often associated with cardiac complications. We present two adult siblings with childhood-onset of weakness progressing to a severe quadriparesis with the additional features of triangular tongues and biventricular cardiac dysfunction. Whole exome sequencing identified compound heterozygous missense mutations that are predicted to be pathogenic in LIMS2. Biopsy of skeletal muscle demonstrated disrupted immunostaining of LIMS2. This is the first report of mutations in LIMS2 and resulting disruption of the integrin linked kinase (ILK)-LIMS-parvin complex associated with LGMD.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Cardiomyopathies/genetics , Genetic Predisposition to Disease/genetics , LIM Domain Proteins/genetics , Membrane Proteins/genetics , Muscular Dystrophies, Limb-Girdle/genetics , Mutation, Missense , Tongue/abnormalities , Adult , Base Sequence , Cardiomyopathies/pathology , Exome/genetics , Female , Heterozygote , Humans , Male , Pedigree , Sequence Analysis, DNA , Severity of Illness Index , Siblings
13.
Clin Genet ; 88(1): 34-40, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25046240

ABSTRACT

Whole-exome sequencing (WES) has transformed our ability to detect mutations causing rare diseases. FORGE (Finding Of Rare disease GEnes) and Care4Rare Canada are nation-wide projects focused on identifying disease genes using WES and translating this technology to patient care. Rare forms of epilepsy are well-suited for WES and we retrospectively selected FORGE and Care4Rare families with clinical descriptions that included childhood-onset epilepsy or seizures not part of a recognizable syndrome or an early-onset encephalopathy where standard-of-care investigations were unrevealing. Nine families met these criteria and a diagnosis was made in seven, and potentially eight, of the families. In the eight families we identified mutations in genes associated with known neurological and epilepsy disorders: ASAH1, FOLR1, GRIN2A (two families), SCN8A, SYNGAP1 and SYNJ1. A novel and rare mutation was identified in KCNQ2 and was likely responsible for the benign seizures segregating in the family though additional evidence would be required to be definitive. In retrospect, the clinical presentation of four of the patients was considered atypical, thereby broadening the phenotypic spectrum of these conditions. Given the extensive clinical and genetic heterogeneity associated with epilepsy, our findings suggest that WES may be considered when a specific gene is not immediately suspected as causal.


Subject(s)
Epilepsy/genetics , Genetic Predisposition to Disease , Mutation , Adolescent , Adult , Brain Diseases/genetics , Child , Child, Preschool , DNA Mutational Analysis , Exome , Female , Humans , Infant , Infant, Newborn , Male , Pedigree , Phenotype , Retrospective Studies
15.
Clin Genet ; 86(2): 172-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-23844659

ABSTRACT

Whole-exome sequencing (WES) has proven its utility in finding novel genes associated with rare conditions and its usefulness is being further demonstrated in expanding the phenotypes of well known diseases. We present here a family with a previously undiagnosed X-linked condition characterized by progressive restriction of joint range of motion, prominence of the supraorbital ridge, audiology issues and hernias. They had an average stature, normal occipitofrontal circumference and intelligence, absence of dysostosis multiplex and otherwise good health. A diagnosis of Hunter syndrome was determined using WES and further supported by biochemical investigations. The phenotype of this family does not correspond to either the severe or attenuated clinical subtypes of Hunter syndrome. As further atypical families are reported, this classification will need to be modified. Our findings highlight the utility of WES in expanding the recognized phenotypic spectrum of known syndromes.


Subject(s)
Exome/genetics , Mucopolysaccharidosis II/genetics , Sequence Analysis, DNA , Adult , Child , Child, Preschool , Family , Female , Humans , Infant , Male , Mucopolysaccharidosis II/diagnostic imaging , Mutation/genetics , Pedigree , Phenotype , Radiography , Reproducibility of Results , Skull/diagnostic imaging
16.
Clin Genet ; 86(6): 558-63, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24164096

ABSTRACT

Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) is a recently delineated, autosomal recessive condition caused by rare mutations in the N-acylsphingosine amidohydrolase 1 (acid ceramidase) ASAH1 gene. It is characterized by motor neuron disease followed by progressive myoclonic seizures and eventual death due to respiratory insufficiency. Here we report an adolescent female who presented with atonic and absence seizures and myoclonic jerks and was later diagnosed as having myoclonic-absence seizures. An extensive genetic and metabolic work-up was unable to arrive at a molecular diagnosis. Whole exome sequencing (WES) identified two rare, deleterious mutations in the ASAH1 gene: c.850G>T;p.Gly284X and c.456A>C;p.Lys152Asn. These mutations were confirmed by Sanger sequencing in the patient and her parents. Functional studies in cultured fibroblasts showed that acid ceramidase was reduced in both overall amount and enzymatic activity. Ceramide level was doubled in the patient's fibroblasts as compared to control cells. The results of the WES and the functional studies prompted an electromyography (EMG) study that showed evidence of motor neuron disease despite only mild proximal muscle weakness. These findings expand the phenotypic spectrum of SMA-PME caused by novel mutations in ASAH1 and highlight the clinical utility of WES for rare, intractable forms of epilepsy.


Subject(s)
Acid Ceramidase/genetics , Epilepsies, Myoclonic/genetics , Muscular Atrophy, Spinal/genetics , Acid Ceramidase/metabolism , Adolescent , Child , Electromyography , Exome , Female , Humans , Motor Neuron Disease/genetics , Motor Neuron Disease/pathology , Muscular Atrophy, Spinal/physiopathology , Mutation
17.
Neurogenetics ; 14(3-4): 181-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23733235

ABSTRACT

We describe the clinical and genetic features of a well-characterized cohort of patients with autosomal recessive hereditary spastic paraplegia (ARHSP) in the province of Ontario. Patients with documented corticospinal tract abnormalities were screened by whole gene sequencing and multiplex ligation probe amplification for mutations in nine genes known to cause ARHSP. Of a cohort of 39 patients, a genetic diagnosis was established in 17 (44 %) and heterozygous mutations were detected in 8 (21 %). Mutations were most frequent in SPG7 (12 patients), followed by SPG11 (10 patients), PNPLA6 (SPG39, 2 patients), and ZFYVE26 (SPG15, 2 patients). Although there are associations between some clinical manifestations of ARHSP and specific genes, many patients are tested at an early stage of the disease when phenotype/genotype correlations are not obvious. Accurate molecular characterization of well-phenotyped cohorts of patients will be essential to establishing the natural history of these rare degenerative disorders to enable future clinical trials.


Subject(s)
Mutation , Spastic Paraplegia, Hereditary/genetics , Adolescent , Adult , Aged , Child , Cohort Studies , Female , Genome-Wide Association Study , Humans , Male , Middle Aged , Pyramidal Tracts/pathology , Spastic Paraplegia, Hereditary/diagnosis , Spastic Paraplegia, Hereditary/pathology , Young Adult
18.
Clin Genet ; 78(5): 424-31, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20618352

ABSTRACT

Bardet-Biedl syndrome (BBS) is a multisystem genetically heterogeneous disorder, the clinical features of which are largely the consequence of ciliary dysfunction. BBS is typically inherited in an autosomal recessive fashion, and mutations in at least 14 genes have been identified. Here, we report the identification of a founder mutation in the BBS2 gene as the cause for the increased incidence of this developmental disorder in the Hutterite population. To ascertain the Hutterite BBS locus, we performed a genome-wide single nucleotide polymorphism (SNP) analysis on a single patient and his three unaffected siblings from a Hutterite family. The analysis identified two large SNP blocks that were homozygous in the patient but not in his unaffected siblings, one of these regions contained the BBS2 gene. Sequence analysis and subsequent RNA studies identified and confirmed a novel splice site mutation, c.472-2A>G, in BBS2. This mutation was also found in homozygous form in three subsequently studied Hutterite BBS patients from two different leuts, confirming that this is a founder mutation in the Hutterite population. Further studies are required to determine the frequency of this mutation and its role, if any, in the expression of other ciliopathies in this population.


Subject(s)
Bardet-Biedl Syndrome/genetics , Ethnicity/genetics , Founder Effect , Adolescent , Adult , Child , Child, Preschool , DNA Mutational Analysis , Genome-Wide Association Study , Humans , Infant , Infant, Newborn , Male , Polymorphism, Single Nucleotide , RNA Splice Sites/genetics , White People/genetics
19.
Hum Genet ; 108(2): 91-7, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11281458

ABSTRACT

Incomplete X-linked congenital stationary night blindness (CSNB) is a recessive, non-progressive eye disorder characterized by abnormal electroretinogram and psychophysical testing and can include impaired night vision, decreased visual acuity, myopia, nystagmus, and strabismus. Including the 20 families previously reported (Bech-Hansen et al. 1998b), we have now analyzed patients from a total of 36 families with incomplete CSNB and identified 20 different mutations in the calcium channel gene CACNA1F. Three of the mutations account for incomplete CSNB in two or more families, and a founder effect is clearly demonstrable for one of these mutations. Of the 20 mutations identified, 14 (70%) are predicted to cause premature protein truncation and six (30%) to cause amino acid substitutions or deletions at conserved positions in the alpha1F protein. In characterizing transcripts of CACNA1F we have identified several splice variants and defined a prototypical sequence based on the location of mutations in splice variants and comparison with the mouse orthologue, Cacnalf.


Subject(s)
Calcium Channels, L-Type , Calcium Channels/genetics , Genetic Linkage , Mutation, Missense , Night Blindness/genetics , RNA Splicing , X Chromosome , Amino Acid Sequence , Animals , Base Sequence , DNA, Complementary , Humans , Mice , Molecular Sequence Data , Night Blindness/congenital , Sequence Homology, Amino Acid
20.
Genomics ; 68(1): 97-100, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10950933

ABSTRACT

A physical map internal to the markers DXS1368 and DXS228 was developed for the p11.4 region of the human X chromosome. Twenty-four BACs and 10 PACs with an average insert size of 149 kb were aligned to form a contig across an estimated 1.4 Mb of DNA. This contig, which has on average fourfold clone coverage, was assembled by STS and EST content analysis using 46 markers, including 8 ESTs, two retinally expressed genes, and 22 new STSs developed from BAC- and PAC-derived DNA sequence. The average intermarker distance was 30 kb. This physical map provides resources for high-resolution mapping as well as suitable clones for large-scale sequencing efforts in Xp11.4, a region known to contain the gene for complete X-linked congenital stationary night blindness.


Subject(s)
DNA/genetics , Night Blindness/genetics , Physical Chromosome Mapping , X Chromosome/genetics , Bacteriophages/genetics , Chromosomes, Bacterial/genetics , Genetic Linkage , Humans , Microsatellite Repeats , Night Blindness/congenital , Sequence Tagged Sites
SELECTION OF CITATIONS
SEARCH DETAIL
...